arrow_back Back to App

Increased Transparency for Emergency Vaccines and Drugs Data

New rules require manufacturers of emergency-use vaccines and drugs to publicly disclose all available data. This aims to enhance public safety and trust in these products. If companies fail to disclose, they may lose legal protections and funding opportunities.
Key points
Manufacturers of emergency-use vaccines and drugs must publicly share product data within 10 days of authorization.
Failure to disclose data can lead to loss of legal protection for the manufacturer and ineligibility for new authorizations or funding.
Citizens can sue the government if it fails to disclose required medical product data.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_5773
Sponsor: Rep. Posey, Bill [R-FL-8]
Process start date: 2023-09-27
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Consumer Vaccine Safety and Protection Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_5773.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-09-27.

What are the main provisions?

Key points include:

  • Manufacturers of emergency-use vaccines and drugs must publicly share product data within 10 days of authorization.
  • Failure to disclose data can lead to loss of legal protection for the manufacturer and ineligibility for new authorizations or funding.
  • Citizens can sue the government if it fails to disclose required medical product data.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Posey, Bill [R-FL-8].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health Courts and Law